nodes	percent_of_prediction	percent_of_DWPC	metapath
Latanoprost—SLCO2B1—Montelukast—chronic obstructive pulmonary disease	0.743	1	CbGbCtD
Latanoprost—Exacerbation of asthma—Formoterol—chronic obstructive pulmonary disease	0.0101	0.0437	CcSEcCtD
Latanoprost—Exacerbation of asthma—Arformoterol—chronic obstructive pulmonary disease	0.0101	0.0437	CcSEcCtD
Latanoprost—Exacerbation of asthma—Salbutamol—chronic obstructive pulmonary disease	0.00955	0.0413	CcSEcCtD
Latanoprost—Iloprost—PDE4A—chronic obstructive pulmonary disease	0.00709	1	CrCbGaD
Latanoprost—Eyelid oedema—Arformoterol—chronic obstructive pulmonary disease	0.00523	0.0226	CcSEcCtD
Latanoprost—Eyelid oedema—Formoterol—chronic obstructive pulmonary disease	0.00523	0.0226	CcSEcCtD
Latanoprost—Sensation of foreign body—Prednisolone—chronic obstructive pulmonary disease	0.00438	0.019	CcSEcCtD
Latanoprost—PTGFR—respiratory system—chronic obstructive pulmonary disease	0.00368	0.211	CbGeAlD
Latanoprost—Dermatitis atopic—Montelukast—chronic obstructive pulmonary disease	0.00349	0.0151	CcSEcCtD
Latanoprost—Conjunctival hyperaemia—Prednisolone—chronic obstructive pulmonary disease	0.00325	0.014	CcSEcCtD
Latanoprost—PTGFR—bronchus—chronic obstructive pulmonary disease	0.00303	0.174	CbGeAlD
Latanoprost—PTGFR—smooth muscle tissue—chronic obstructive pulmonary disease	0.00296	0.17	CbGeAlD
Latanoprost—Urinary tract infection—Roflumilast—chronic obstructive pulmonary disease	0.00283	0.0122	CcSEcCtD
Latanoprost—PTGFR—trachea—chronic obstructive pulmonary disease	0.00272	0.156	CbGeAlD
Latanoprost—Inflammation—Formoterol—chronic obstructive pulmonary disease	0.00272	0.0118	CcSEcCtD
Latanoprost—Inflammation—Arformoterol—chronic obstructive pulmonary disease	0.00272	0.0118	CcSEcCtD
Latanoprost—Inflammation—Salbutamol—chronic obstructive pulmonary disease	0.00257	0.0111	CcSEcCtD
Latanoprost—Connective tissue disorder—Roflumilast—chronic obstructive pulmonary disease	0.00257	0.0111	CcSEcCtD
Latanoprost—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00235	0.0102	CcSEcCtD
Latanoprost—Embolism—Prednisolone—chronic obstructive pulmonary disease	0.00223	0.00962	CcSEcCtD
Latanoprost—Keratitis—Prednisolone—chronic obstructive pulmonary disease	0.0022	0.00953	CcSEcCtD
Latanoprost—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.0022	0.0095	CcSEcCtD
Latanoprost—Eczema—Montelukast—chronic obstructive pulmonary disease	0.00209	0.00903	CcSEcCtD
Latanoprost—SLCO2B1—respiratory system—chronic obstructive pulmonary disease	0.00203	0.116	CbGeAlD
Latanoprost—Eczema—Salbutamol—chronic obstructive pulmonary disease	0.00201	0.0087	CcSEcCtD
Latanoprost—Angina pectoris—Tiotropium—chronic obstructive pulmonary disease	0.002	0.00864	CcSEcCtD
Latanoprost—PTGFR—lung—chronic obstructive pulmonary disease	0.00195	0.112	CbGeAlD
Latanoprost—Dermatitis atopic—Prednisolone—chronic obstructive pulmonary disease	0.00193	0.00835	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00192	0.00831	CcSEcCtD
Latanoprost—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00191	0.00826	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Tiotropium—chronic obstructive pulmonary disease	0.00191	0.00824	CcSEcCtD
Latanoprost—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00182	0.00786	CcSEcCtD
Latanoprost—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.0018	0.00779	CcSEcCtD
Latanoprost—Urinary tract infection—Tiotropium—chronic obstructive pulmonary disease	0.00178	0.00769	CcSEcCtD
Latanoprost—Stinging—Prednisolone—chronic obstructive pulmonary disease	0.00176	0.00763	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00169	0.00731	CcSEcCtD
Latanoprost—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.00169	0.0073	CcSEcCtD
Latanoprost—Eye irritation—Prednisolone—chronic obstructive pulmonary disease	0.00167	0.00723	CcSEcCtD
Latanoprost—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.00166	0.00716	CcSEcCtD
Latanoprost—Asthma—Formoterol—chronic obstructive pulmonary disease	0.00166	0.00716	CcSEcCtD
Latanoprost—Asthma—Montelukast—chronic obstructive pulmonary disease	0.00162	0.00701	CcSEcCtD
Latanoprost—Embolism—Prednisone—chronic obstructive pulmonary disease	0.00162	0.00699	CcSEcCtD
Latanoprost—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.00161	0.00698	CcSEcCtD
Latanoprost—Angina pectoris—Arformoterol—chronic obstructive pulmonary disease	0.00161	0.00697	CcSEcCtD
Latanoprost—Angina pectoris—Formoterol—chronic obstructive pulmonary disease	0.00161	0.00697	CcSEcCtD
Latanoprost—Bronchitis—Formoterol—chronic obstructive pulmonary disease	0.00159	0.00688	CcSEcCtD
Latanoprost—Bronchitis—Arformoterol—chronic obstructive pulmonary disease	0.00159	0.00688	CcSEcCtD
Latanoprost—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.00156	0.00676	CcSEcCtD
Latanoprost—Bronchitis—Montelukast—chronic obstructive pulmonary disease	0.00156	0.00674	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Formoterol—chronic obstructive pulmonary disease	0.00154	0.00665	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Arformoterol—chronic obstructive pulmonary disease	0.00154	0.00665	CcSEcCtD
Latanoprost—Angina pectoris—Salbutamol—chronic obstructive pulmonary disease	0.00152	0.00658	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Montelukast—chronic obstructive pulmonary disease	0.00151	0.00652	CcSEcCtD
Latanoprost—Bronchitis—Salbutamol—chronic obstructive pulmonary disease	0.0015	0.0065	CcSEcCtD
Latanoprost—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00148	0.0064	CcSEcCtD
Latanoprost—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.00628	CcSEcCtD
Latanoprost—Urinary tract infection—Arformoterol—chronic obstructive pulmonary disease	0.00143	0.0062	CcSEcCtD
Latanoprost—Conjunctivitis—Arformoterol—chronic obstructive pulmonary disease	0.00143	0.0062	CcSEcCtD
Latanoprost—Conjunctivitis—Formoterol—chronic obstructive pulmonary disease	0.00143	0.0062	CcSEcCtD
Latanoprost—Urinary tract infection—Formoterol—chronic obstructive pulmonary disease	0.00143	0.0062	CcSEcCtD
Latanoprost—Conjunctivitis—Montelukast—chronic obstructive pulmonary disease	0.00141	0.00608	CcSEcCtD
Latanoprost—Dermatitis atopic—Prednisone—chronic obstructive pulmonary disease	0.0014	0.00607	CcSEcCtD
Latanoprost—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.00138	0.00598	CcSEcCtD
Latanoprost—Conjunctivitis—Salbutamol—chronic obstructive pulmonary disease	0.00135	0.00586	CcSEcCtD
Latanoprost—Urinary tract infection—Salbutamol—chronic obstructive pulmonary disease	0.00135	0.00586	CcSEcCtD
Latanoprost—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00135	0.00582	CcSEcCtD
Latanoprost—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.0013	0.00563	CcSEcCtD
Latanoprost—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.0013	0.00563	CcSEcCtD
Latanoprost—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.00128	0.00551	CcSEcCtD
Latanoprost—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00532	CcSEcCtD
Latanoprost—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00123	0.0053	CcSEcCtD
Latanoprost—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00122	0.00526	CcSEcCtD
Latanoprost—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00122	0.00526	CcSEcCtD
Latanoprost—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00121	0.00524	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00121	0.00522	CcSEcCtD
Latanoprost—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00119	0.00516	CcSEcCtD
Latanoprost—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00119	0.00516	CcSEcCtD
Latanoprost—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00117	0.00506	CcSEcCtD
Latanoprost—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00117	0.00506	CcSEcCtD
Latanoprost—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00117	0.00505	CcSEcCtD
Latanoprost—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00117	0.00504	CcSEcCtD
Latanoprost—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00116	0.00502	CcSEcCtD
Latanoprost—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.00495	CcSEcCtD
Latanoprost—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00113	0.0049	CcSEcCtD
Latanoprost—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00487	CcSEcCtD
Latanoprost—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00112	0.00482	CcSEcCtD
Latanoprost—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00112	0.00482	CcSEcCtD
Latanoprost—SLCO2B1—lung—chronic obstructive pulmonary disease	0.00108	0.0617	CbGeAlD
Latanoprost—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00106	0.00459	CcSEcCtD
Latanoprost—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00455	CcSEcCtD
Latanoprost—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000982	0.00425	CcSEcCtD
Latanoprost—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000982	0.00425	CcSEcCtD
Latanoprost—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000982	0.00425	CcSEcCtD
Latanoprost—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000982	0.00425	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000975	0.00422	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000975	0.00422	CcSEcCtD
Latanoprost—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00097	0.00419	CcSEcCtD
Latanoprost—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00097	0.00419	CcSEcCtD
Latanoprost—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000962	0.00416	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000955	0.00413	CcSEcCtD
Latanoprost—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000941	0.00407	CcSEcCtD
Latanoprost—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000941	0.00407	CcSEcCtD
Latanoprost—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000927	0.00401	CcSEcCtD
Latanoprost—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000927	0.00401	CcSEcCtD
Latanoprost—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000923	0.00399	CcSEcCtD
Latanoprost—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000923	0.00399	CcSEcCtD
Latanoprost—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000922	0.00399	CcSEcCtD
Latanoprost—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000916	0.00396	CcSEcCtD
Latanoprost—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000914	0.00395	CcSEcCtD
Latanoprost—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000914	0.00395	CcSEcCtD
Latanoprost—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000904	0.00391	CcSEcCtD
Latanoprost—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000896	0.00387	CcSEcCtD
Latanoprost—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000889	0.00384	CcSEcCtD
Latanoprost—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000875	0.00378	CcSEcCtD
Latanoprost—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000872	0.00377	CcSEcCtD
Latanoprost—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000863	0.00373	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000858	0.00371	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000858	0.00371	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00084	0.00363	CcSEcCtD
Latanoprost—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000839	0.00363	CcSEcCtD
Latanoprost—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000839	0.00363	CcSEcCtD
Latanoprost—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000825	0.00357	CcSEcCtD
Latanoprost—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000818	0.00354	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00081	0.0035	CcSEcCtD
Latanoprost—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000805	0.00348	CcSEcCtD
Latanoprost—Pain—Formoterol—chronic obstructive pulmonary disease	0.000805	0.00348	CcSEcCtD
Latanoprost—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000793	0.00343	CcSEcCtD
Latanoprost—Pain—Montelukast—chronic obstructive pulmonary disease	0.000789	0.00341	CcSEcCtD
Latanoprost—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00078	0.00337	CcSEcCtD
Latanoprost—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000779	0.00337	CcSEcCtD
Latanoprost—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000777	0.00336	CcSEcCtD
Latanoprost—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000775	0.00335	CcSEcCtD
Latanoprost—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000771	0.00333	CcSEcCtD
Latanoprost—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00076	0.00329	CcSEcCtD
Latanoprost—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000736	0.00318	CcSEcCtD
Latanoprost—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000735	0.00318	CcSEcCtD
Latanoprost—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000731	0.00316	CcSEcCtD
Latanoprost—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000666	0.00288	CcSEcCtD
Latanoprost—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000666	0.00288	CcSEcCtD
Latanoprost—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000652	0.00282	CcSEcCtD
Latanoprost—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000629	0.00272	CcSEcCtD
Latanoprost—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000625	0.0027	CcSEcCtD
Latanoprost—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000623	0.00269	CcSEcCtD
Latanoprost—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000623	0.00269	CcSEcCtD
Latanoprost—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00061	0.00264	CcSEcCtD
Latanoprost—Rash—Formoterol—chronic obstructive pulmonary disease	0.000594	0.00257	CcSEcCtD
Latanoprost—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000594	0.00257	CcSEcCtD
Latanoprost—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000593	0.00256	CcSEcCtD
Latanoprost—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000593	0.00256	CcSEcCtD
Latanoprost—Headache—Formoterol—chronic obstructive pulmonary disease	0.00059	0.00255	CcSEcCtD
Latanoprost—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00059	0.00255	CcSEcCtD
Latanoprost—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000589	0.00255	CcSEcCtD
Latanoprost—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000588	0.00254	CcSEcCtD
Latanoprost—Rash—Montelukast—chronic obstructive pulmonary disease	0.000581	0.00251	CcSEcCtD
Latanoprost—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000581	0.00251	CcSEcCtD
Latanoprost—Headache—Montelukast—chronic obstructive pulmonary disease	0.000578	0.0025	CcSEcCtD
Latanoprost—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00056	0.00242	CcSEcCtD
Latanoprost—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00056	0.00242	CcSEcCtD
Latanoprost—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000557	0.00241	CcSEcCtD
Latanoprost—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000525	0.00227	CcSEcCtD
Latanoprost—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000512	0.00222	CcSEcCtD
Latanoprost—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00051	0.0022	CcSEcCtD
Latanoprost—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000454	0.00196	CcSEcCtD
Latanoprost—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000436	0.00188	CcSEcCtD
Latanoprost—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000428	0.00185	CcSEcCtD
Latanoprost—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000386	0.00167	CcSEcCtD
Latanoprost—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000384	0.00166	CcSEcCtD
Latanoprost—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000382	0.00165	CcSEcCtD
Latanoprost—Oedema—Prednisone—chronic obstructive pulmonary disease	0.00037	0.0016	CcSEcCtD
Latanoprost—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000363	0.00157	CcSEcCtD
Latanoprost—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00036	0.00156	CcSEcCtD
Latanoprost—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000338	0.00146	CcSEcCtD
Latanoprost—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000337	0.00146	CcSEcCtD
Latanoprost—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000321	0.00139	CcSEcCtD
Latanoprost—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000321	0.00139	CcSEcCtD
Latanoprost—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000319	0.00138	CcSEcCtD
Latanoprost—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000262	0.00113	CcSEcCtD
Latanoprost—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000245	0.00106	CcSEcCtD
Latanoprost—PTGFR—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.000236	0.259	CbGpPWpGaD
Latanoprost—Rash—Prednisone—chronic obstructive pulmonary disease	0.000234	0.00101	CcSEcCtD
Latanoprost—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000233	0.00101	CcSEcCtD
Latanoprost—Headache—Prednisone—chronic obstructive pulmonary disease	0.000232	0.001	CcSEcCtD
Latanoprost—SLCO2B1—Transport of organic anions—ALB—chronic obstructive pulmonary disease	7.22e-05	0.0791	CbGpPWpGaD
Latanoprost—PTGFR—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	5.77e-05	0.0632	CbGpPWpGaD
Latanoprost—PTGFR—GPCRs, Other—CXCR2—chronic obstructive pulmonary disease	4.23e-05	0.0464	CbGpPWpGaD
Latanoprost—SLCO2B1—Transport of vitamins, nucleosides, and related molecules—ALB—chronic obstructive pulmonary disease	2.68e-05	0.0293	CbGpPWpGaD
Latanoprost—PTGFR—GPCRs, Other—ADRB2—chronic obstructive pulmonary disease	2.66e-05	0.0291	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	2.48e-05	0.0272	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	2.21e-05	0.0242	CbGpPWpGaD
Latanoprost—PTGFR—GPCRs, Other—HTR2A—chronic obstructive pulmonary disease	2.08e-05	0.0228	CbGpPWpGaD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	1.84e-05	0.0202	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	1.58e-05	0.0173	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	1.33e-05	0.0146	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	1.2e-05	0.0132	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	1.19e-05	0.0131	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	1.17e-05	0.0129	CbGpPWpGaD
Latanoprost—PTGFR—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	1.17e-05	0.0128	CbGpPWpGaD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	1.15e-05	0.0126	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	1.11e-05	0.0122	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	1.04e-05	0.0114	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	9.9e-06	0.0109	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	9.89e-06	0.0108	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	9.83e-06	0.0108	CbGpPWpGaD
Latanoprost—SLC22A1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	9.57e-06	0.0105	CbGpPWpGaD
Latanoprost—PTGFR—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	9.02e-06	0.00988	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	9e-06	0.00986	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	8.83e-06	0.00968	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	8.41e-06	0.00922	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	7.73e-06	0.00847	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	7.64e-06	0.00837	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	7.53e-06	0.00825	CbGpPWpGaD
Latanoprost—SLC22A1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	7.33e-06	0.00804	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	6.78e-06	0.00743	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	6.73e-06	0.00737	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	6.16e-06	0.00675	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	5.95e-06	0.00653	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	5.88e-06	0.00645	CbGpPWpGaD
Latanoprost—SLCO2B1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	5.75e-06	0.0063	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.87e-06	0.00533	CbGpPWpGaD
Latanoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	4.77e-06	0.00523	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	4.71e-06	0.00516	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.51e-06	0.00495	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.25e-06	0.00466	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—APIP—chronic obstructive pulmonary disease	4.24e-06	0.00465	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.86e-06	0.00423	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.8e-06	0.00417	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.64e-06	0.00399	CbGpPWpGaD
Latanoprost—PTGFR—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.64e-06	0.00398	CbGpPWpGaD
Latanoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	3.62e-06	0.00397	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.45e-06	0.00378	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.33e-06	0.00364	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.02e-06	0.00331	CbGpPWpGaD
Latanoprost—SLCO2B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.92e-06	0.0032	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.81e-06	0.00308	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GC—chronic obstructive pulmonary disease	2.73e-06	0.003	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.66e-06	0.00291	CbGpPWpGaD
Latanoprost—SLC22A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	2.58e-06	0.00282	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.54e-06	0.00279	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.47e-06	0.00271	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.28e-06	0.0025	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.18e-06	0.00239	CbGpPWpGaD
Latanoprost—PTGFR—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.05e-06	0.00225	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.04e-06	0.00223	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.87e-06	0.00204	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.85e-06	0.00203	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.78e-06	0.00196	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.66e-06	0.00182	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.49e-06	0.00164	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.48e-06	0.00162	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.36e-06	0.00149	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.35e-06	0.00148	CbGpPWpGaD
Latanoprost—SLC22A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.31e-06	0.00143	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.3e-06	0.00143	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.24e-06	0.00136	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.24e-06	0.00136	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.1e-06	0.00121	CbGpPWpGaD
Latanoprost—PTGFR—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.05e-06	0.00115	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.04e-06	0.00113	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.02e-06	0.00112	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.97e-07	0.00109	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.51e-07	0.00104	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.02e-07	0.000988	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.95e-07	0.000981	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.22e-07	0.0009	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.06e-07	0.000883	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.76e-07	0.000741	CbGpPWpGaD
Latanoprost—PTGFR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.19e-07	0.000678	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—ALB—chronic obstructive pulmonary disease	6.13e-07	0.000672	CbGpPWpGaD
Latanoprost—SLC22A1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.86e-07	0.000643	CbGpPWpGaD
